Suresh Kumar Rayala
5PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jan 13, 2025
Novel Combination Therapy Targeting Oncogenic Signaling Kinase P21-Activated Kinase 1 and Chemotherapeutic Drugs Against Triple-Negative Breast Cancer.Inemai Ezhil, Abirami Seetharaman, Rahul Kanumuri
|Feb 12, 2024
Expression of cell surface zinc transporter LIV1 in triple negative breast cancer is an indicator of poor prognosis and therapy failure.Roshni Saravanan, Vaishnavi Balasubramanian, Sandhya Sundaram
|Oct 01, 2022
Zinc transporter LIV1: A promising cell surface target for triple negative breast cancer.Roshni Saravanan, Vaishnavi Balasubramanian, Srikanth Swamy Swaroop Balamurugan
|Jul 13, 2021
Small peptide inhibitor from the sequence of RUNX3 disrupts PAK1-RUNX3 interaction and abrogates its phosphorylation-dependent oncogenic function.Rahul Kanumuri, Aruna Kumar Chelluboyina, Jayashree Biswal
|Aug 05, 2018
Mechanics of PAK1-A new molecular player in the arena of skin cancer.Swarnalatha Beesetti, Rohan P Surabhi, Suresh K Rayala
Pageof 1
